This inventor holds 4 USPTO granted patents. Top assignees: Fujisawa Pharmaceutical Company, Ltd., Astra Aktiebolag. Active years: 1993-1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1993-1999
Title: Shigeo Nakanishi: Innovator in Pharmaceutical Composition
Introduction
Shigeo Nakanishi is a notable inventor based in Neyagawa, Japan. He has made significant contributions to the field of pharmaceuticals, holding a total of 4 patents. His work primarily focuses on innovative compositions that enhance medical treatments.
Latest Patents
Among his latest patents, Nakanishi has developed a pharmaceutical emulsion composition or solution composition in an organic solvent that contains a compound with immunosuppressive activity. This invention aims to improve therapeutic outcomes for patients requiring immunosuppressive treatments. Additionally, he has created an injection and injection kit containing omeprazole and its analogs, which are crucial for various medical applications.
Career Highlights
Throughout his career, Nakanishi has worked with prominent companies in the pharmaceutical industry, including Fujisawa Pharmaceutical Company, Ltd. and Astra Aktiebolag. His experience in these organizations has allowed him to refine his expertise and contribute to groundbreaking innovations in drug formulation.
Collaborations
Nakanishi has collaborated with esteemed colleagues such as Iwao Yamanaka and Tetsuo Tominaga. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in pharmaceutical research.
Conclusion
Shigeo Nakanishi's contributions to pharmaceutical innovations demonstrate his commitment to improving healthcare through inventive solutions. His patents reflect a deep understanding of the complexities of drug formulation and its impact on patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
